Dame Emma Walmsley
Chief Executive Officer (CEO) at GSK
Board
Since April 1, 2017
Age
54 years
Education
Holds an MA in Classics and Modern Languages from Oxford University.
Tenure
Joined GSK in 2010 and later advanced into leadership roles, becoming CEO on April 1, 2017.
Also at GSK
DW
Deborah Waterhouse
President of Global Health at GSK
JF
James Ford
Senior Vice President (SVP) and Group General Counsel, Legal and Compliance
JB
Julie Brown
Chief Financial Officer (CFO)
About
Dame Emma Walmsley is a British executive who has significantly contributed to GSK since joining the company in 2010.
She has a strong academic foundation, holding an MA in Classics and Modern Languages from Oxford University, which has complemented her extensive career in leadership roles within the company.
After beginning her career at GSK in 2010, she advanced through various roles, including serving as CEO of GSK Consumer Healthcare, before being appointed as the Chief Executive Officer on April 1, 2017.
Her tenure has been marked by transformative initiatives aimed at innovation and strategic growth, further solidifying her reputation as a forward-thinking leader in the healthcare sector.